Shukra Pharmaceuticals informs about separate meeting of independent directors
Shukra Pharmaceuticals has informed that a separate meeting of the Independent Directors of the company will be held on Monday, 16th March, 2026 at the Registered Office of the Company to transact the following business: 1) To review the performance of Non-Independent Directors and the Board as a whole. 2) To Review the performance of the Chairman of the Company. 3) To access the Quantity, Quality and timeliness of flow of information. 4) Any other business with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.
